< %=imgalt%>
Home / Technology News / 2008 / February 2008 / February 9, 2008
Early stage test that can detect breast cancer from hair strands developed
Breast cancer

Obese at increased cancer risk

New approach to re-sensitize treatment resistant tumours

33rd ESMO Congress in Stockholm, 12-16 September 2008

Antioxidant shows promise to prevent chemobrain memory loss

More on Breast cancer

Top News

Chiranjeevi launches names his new political party - Praja Rajyam

Nuke deal will put India in league with elite nations: Sonia

Voters doubt Obamas ability to keep US safe from terrorism

Sadie Frost and 30 friends down £50k worth of Crystal champagne!

Indias Firstsource stake put on sale

Jayawardena, Yuvraj to hold media conferences in Dubai on Tuesday

Olive oil had a large number of usages in ancient Greece

Now, rubber tyres to get rid of waist tyres!

Early stage test that can detect breast cancer from hair strands developed

Scientists have made a breakthrough in breast cancer treatments by developing a test that can successfully detect the disease from a few strands of hair.

London, Feb 9 : Scientists have made a breakthrough in breast cancer treatments by developing a test that can successfully detect the disease from a few strands of hair.

The test, known as Fermiscan, is capable of detecting the disease in the early stages, which is easiest to treat.

It helps in diagnosing the cancer from just 20 strands of hair, about 2.5cm long in younger women, reports New Scientist magazine.

One in every five cases of women under 50s suffering from breast cancer have denser breast that are difficult to screen with mammography.

Fermiscan can also help in identifying the tumours surfacing in the three-year gap between the breast X-rays or mammograms given to the over-50s regularly.

When a normal hair is put under a microscope, it appears as series of arcs and women with breast cancer have a distinctive ring superimposed on to these arcs.

The test is expected to be up for sale within a few months.

Dr Alison Ross, of Cancer Research UK, said that the 220-dollar test could miss cancer in people with the disease but give a false positive in healthy women.

ANI

September 8, 2008

September 7, 2008

September 6, 2008

September 5, 2008

September 4, 2008

September 3, 2008